Clinical Trial

The Significance and Indications of Surgery for Synchronous Liver Metastatic Pancreatic Cancer

Study acronym: PCLM:CSSG
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 16, 2025 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
To explore the clinical characteristics of pancreatic cancer patients with liver metastases who can benefit from surgery, and to develop evaluation criteria for surgical indications, so as to provide basis for comprehensive treatment strategies for advanced pancreatic cancer patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-06.
Trial Details
NCT Number NCT06873178
Lead Sponsor China-Japan Friendship Hospital
Collaborators: Peking University First Hospital, Chongqing General Hospital, Tongji Hospital, Zhejiang Provincial People's Hospital
Conditions Pancreatic Cancer, Liver Metastases, Surgery, Adjuvant Therapy
Enrollment 50 participants
Start Date 2024-08-23
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-16